April 09, 2024

Lisata’s Bone Cancer Candidate Receives Orphan Drug Designation

Lisata Therapeutics (Nasdaq: LSTA) has received FDA Orphan Drug Designation for LSTA1, its lead product candidate, for the treatment of osteosarcoma. Osteosarcoma is a rare cancer that can develop in children, adolescents and young adults. Approximately 800 cases are diagnosed in the US each year. The company’s share price rose more than 10% in morning… [Read More]
April 09, 2024

PRISM NextGen Tech and AI Newest Addition, Beamr (BMR) Up ~27%, Teams Up with Nvidia on Breakthrough Video Application

Today the recent AI addition to the PRISM NextGen Tech and AI Index, Beamr Imaging, Ltd. (BMR) is leading the index on its recent announcement  that cites its plan to demonstrate a real-time video optimization application with the NVIDIA Holoscan for Media. Holoscan is a software-defined platform that provides developers with the easy ability to create… [Read More]
April 09, 2024

Tilray Brands (TLRY) Gets Smoked Out on Q3 Earnings, Trading Down 20%

PRISM Cannabis Index laggard, Tilray Brands (TLRY) announced disappointing Q3 earnings that missed on Q3 EPS ($0.12) vs Factset ($0.05) as well as quarterly revenues $188.3M vs Factset $198.3M. Furthermore, the company cited due to delayed timing of cash collection on various asset sales, the generation of positive adjusted free cash flow for the full… [Read More]
April 09, 2024

Market Anticipation Heightens Ahead of Inflation Report Amid Bond Rebound and Corporate Developments

The bond market saw a rebound as traders anticipated the release of crucial inflation data, influencing the Federal Reserve’s future actions. Ahead of Wednesday’s consumer price index report, 10-year Treasury yields decreased, signaling a calm market session. Despite recent resilience in US economic data and Federal Reserve officials’ skepticism towards easing, the market’s expectation for… [Read More]
April 09, 2024

Oil Prices Fall as Geopolitical Tensions Ease

Israel withdrew troops from southern Gaza over the weekend, reducing its military presence in the area to their lowest levels since October 2023. Oil prices had gained more than 4% last week as tensions mounted between Israel and Iran, and have since dropped in response to the news that Israel would leave just one brigade… [Read More]
April 09, 2024

Prism Premarket Moves : American Eagle Outfitters, Ally Financial, Molson Coors Beverage and more

Take a look at the corporations gaining attention ahead of the opening bell: American Eagle Outfitters — The retailer’s shares surged 4% following a promotion from JPMorgan to overweight from neutral. The firm highlighted the company’s merchandising strategies and operational shifts as the reasons for this upgrade. Freeport-McMoRan — The American mining company’s shares leapt… [Read More]
April 08, 2024

Alkermes Presents Long Term Data Supporting LYBALVI in Schizophrenia and Bipolar I Disorder

Alkermes plc (Nasdaq: ALKS) has presented clinical data from its Phase 3 open-label extension study of LYBALVI® (olanzapine and samidorphan) at the 2024 Congress of the Schizophrenia International Research Society (SIRS) in Florence, Italy this month. Alkermes’ study assessed the long-term safety, tolerability and durability of treatment effect of LYBALVI for up to four years… [Read More]
April 08, 2024

PRISM Market Moves on Monday: Tesla Outperforms on Robotaxi News; Paramount and Kroger Drop

US equities are trading higher on Monday afternoon after a rally on Friday. Outperformers on Monday include EVs, led by Tesla ($TSLA), beauty, regional banks, semis, tobacco, airlines, and cruise lines. Dollar stores, homebuilders, biotech, drug stores, oil majors, refiners, casinos, healthcare services, and tech hardware are underperforming. Treasuries are weaker, the Dollar is narrowly… [Read More]
April 08, 2024

Lipella Pharmaceuticals Advances Bladder Cancer Candidate

Clinical stage biotechnology company, Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), will publish an abstract at the 2024 American Society of Clinical Oncology (ASCO) meeting which will take place from May 31 through June 4 in Chicago, Illinois. The abstract, titled “Intravesical local administration of pembrolizumab for treatment of bladder cancer: A novel strategy to minimize toxicity”… [Read More]
April 08, 2024

Inflation Concerns Drive Bond Yields to 2024 Peaks: Market Overview

  As Wall Street anticipates the upcoming consumer price index release on Wednesday, bond yields have surged, marking a 2024 high amid easing geopolitical tensions and anticipation of crucial inflation data. The bond market saw a downturn at the start of the week, with 10-year Treasury yields reaching their highest point since November, nearing the… [Read More]
April 08, 2024

Fox Business Varney & Co. Features MedTech Emerger NeuroOne® CEO Dave Rosa

Chief Executive Officer for the emerging MedTech company NeuroOne Medical Technologies Corporation (NMTC) was featured on the Fox Business Network’s news and talk show, Varney & Co. this past Wednesday. The company released an official announcement highlighting the appearance in which they discussed a new brain implant that could have a significant impact on neurosurgery…. [Read More]